Hybrid Magnetic Resonance Imaging and Positron Emission Tomography With Fluorodeoxyglucose to Diagnose Active Cardiac Sarcoidosis
Top Cited Papers
- 14 June 2017
- journal article
- research article
- Published by Elsevier BV in JACC: Cardiovascular Imaging
- Vol. 11 (1), 94-107
- https://doi.org/10.1016/j.jcmg.2017.02.021
Abstract
No abstract availableKeywords
This publication has 18 references indexed in Scilit:
- Prognostic Value of Myocardial Scarring on CMR in Patients With Cardiac SarcoidosisJACC: Cardiovascular Imaging, 2016
- Cardiac SarcoidosisJournal of the American College of Cardiology, 2016
- HRS Expert Consensus Statement on the Diagnosis and Management of Arrhythmias Associated With Cardiac SarcoidosisHeart Rhythm, 2014
- Recommendations for 18F-fluorodeoxyglucose positron emission tomography imaging for cardiac sarcoidosis: Japanese Society of Nuclear Cardiology RecommendationsAnnals of Nuclear Medicine, 2014
- CMR Imaging Predicts Death and Other Adverse Events in Suspected Cardiac SarcoidosisJACC: Cardiovascular Imaging, 2013
- Detection of Myocardial Damage in Patients With SarcoidosisCirculation, 2009
- Myocardial imaging with 18F-fluoro-2-deoxyglucose positron emission tomography and magnetic resonance imaging in sarcoidosisEuropean Journal of Nuclear Medicine and Molecular Imaging, 2007
- SarcoidosisThe New England Journal of Medicine, 2007
- Focal uptake on 18F-fluoro-2-deoxyglucose positron emission tomography images indicates cardiac involvement of sarcoidosis†European Heart Journal, 2005
- Histologic diagnostic rate of cardiac sarcoidosis: Evaluation of endomyocardial biopsiesAmerican Heart Journal, 1999